ClinConnect ClinConnect Logo
Search / Trial NCT05818800

Pilot Study Based on Technology Solutions for Hypertension Care

Launched by ISTITUTO AUXOLOGICO ITALIANO · Apr 5, 2023

Trial Information

Current as of August 02, 2025

Completed

Keywords

Digital Technology Hypertension Blood Pressure

ClinConnect Summary

The study falls within the scope of the HSMonitor project, a pre-commercial tender for the development of telematics solutions aimed at optimising patient health status and disease management. Specifically, the aim of this study is to test whether the adoption of HSMonitor solutions by healthcare professionals and patients improves the management of patients with high blood pressure.

This will be a randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions or to standard care.

The present pilot study is planned to be carried ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed with essential hypertension (\>140/90 mmHg or normal BP with antihypertensive treatment)
  • Basic ICT knowledge and ability to access the internet at home and on mobile devices
  • aged 18+
  • ability to provide written informed consent, giving informed consent.
  • written informed consent
  • Exclusion Criteria:
  • inability to consent
  • chronic renal replacement therapy (haemodialysis, peritoneal dialysis or transplantation) or if, at baseline, there is a history of active malignancy within the last five years
  • pregnancy
  • illiterate
  • younger than 18 years
  • being a prisoner
  • being institutionalized
  • the patient is mentally or psychiatrically ill
  • the patient has barriers to understand the implications of participation to the study
  • the patient is critically ill or dying
  • the patient is extremely poor
  • the patient has a learning disability
  • the patient is sedated or unconscious
  • the patient is a refugee with no permanent permission to stay
  • the patient does not have a good command of the language
  • the patient has problems in cognitive, juridical, and deferential dimensions

About Istituto Auxologico Italiano

Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.

Locations

Milan, , Italy

Patients applied

0 patients applied

Trial Officials

Gianfranco Parati, MD

Principal Investigator

Istituto Auxologico Italiano

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported